Related Experiment Videos

Genetics and cystic fibrosis: a focus on carrier testing

Pediatric Nursing
|September 1, 1995
PubMed

Insights

Genetic testing for cystic fibrosis (CF) mutations enables carrier screening for relatives. However, its application in minors, newborns, and the general public raises ethical considerations, with pediatric nurses playing a key support role.

Area of Science:

  • Medical Genetics
  • Pediatric Nursing
  • Genetic Counseling

Background:

  • Identification of mutations in the cystic fibrosis (CF) gene facilitates carrier testing for individuals with CF and their families.
  • The application of CF genetic testing extends to potentially controversial areas, including minors, newborn screening, and general public screening.

Purpose of the Study:

  • To explore the implications of CF gene mutation identification for carrier testing.
  • To examine the controversial applications of CF genetic testing.
  • To define the role of pediatric nurses in genetic aspects of CF.

Main Methods:

  • Literature review on CF genetic testing and its ethical considerations.
  • Analysis of current practices in carrier testing and newborn screening for CF.
  • Role delineation for pediatric nurses in genetic counseling and support for CF.

Main Results:

  • CF gene mutation identification allows for targeted carrier testing within families.
  • Controversial uses of CF genetic testing include minors, newborn screening, and general population screening.
  • Pediatric nurses are vital in providing information, advocacy, referral, and psychosocial support.

Conclusions:

  • CF genetic testing offers benefits for family member screening but presents ethical challenges in broader applications.
  • Pediatric nurses are essential in navigating the complexities of CF genetic information and support.
  • Further discussion is needed on the ethical framework for widespread CF genetic screening.

Related Concept Videos